vs
Apellis Pharmaceuticals, Inc.(APLS)与Kosmos Energy Ltd.(KOS)财务数据对比。点击上方公司名可切换其他公司
Kosmos Energy Ltd.的季度营收约是Apellis Pharmaceuticals, Inc.的1.5倍($294.6M vs $199.9M),Apellis Pharmaceuticals, Inc.同比增速更快(-5.9% vs -25.9%),过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高(7.7% vs -16.5%)
Apellis Pharmaceuticals是一家临床阶段生物制药企业,专注于开发调节补体系统的靶向疗法,适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病,核心市场为美国及欧盟地区。
科斯莫斯能源是一家美国上游石油企业,总部位于得克萨斯州达拉斯。公司目前在加纳、赤道几内亚近海以及墨西哥湾开展油气生产与开发业务,在毛里塔尼亚、塞内加尔近海拥有开发项目,还在纳米比亚、圣多美和普林西比、苏里南近海持有勘探许可。
APLS vs KOS — 直观对比
营收规模更大
KOS
是对方的1.5倍
$199.9M
营收增速更快
APLS
高出20.0%
-25.9%
两年增速更快
APLS
近两年复合增速
-16.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $199.9M | $294.6M |
| 净利润 | $-59.0M | — |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | -125.7% |
| 净利率 | -29.5% | — |
| 营收同比 | -5.9% | -25.9% |
| 净利润同比 | -62.2% | — |
| 每股收益(稀释后) | $-0.40 | $-0.80 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
APLS
KOS
| Q4 25 | $199.9M | $294.6M | ||
| Q3 25 | $458.6M | $311.0M | ||
| Q2 25 | $178.5M | $392.6M | ||
| Q1 25 | $166.8M | $290.1M | ||
| Q4 24 | $212.5M | $397.6M | ||
| Q3 24 | $196.8M | $407.8M | ||
| Q2 24 | $199.7M | $447.8M | ||
| Q1 24 | $172.3M | $422.3M |
净利润
APLS
KOS
| Q4 25 | $-59.0M | — | ||
| Q3 25 | $215.7M | $-124.3M | ||
| Q2 25 | $-42.2M | $-87.7M | ||
| Q1 25 | $-92.2M | $-110.6M | ||
| Q4 24 | $-36.4M | — | ||
| Q3 24 | $-57.4M | $45.0M | ||
| Q2 24 | $-37.7M | $59.8M | ||
| Q1 24 | $-66.4M | $91.7M |
营业利润率
APLS
KOS
| Q4 25 | -25.6% | -125.7% | ||
| Q3 25 | 48.7% | -34.2% | ||
| Q2 25 | -18.6% | -16.2% | ||
| Q1 25 | -50.0% | -32.4% | ||
| Q4 24 | -12.3% | -8.5% | ||
| Q3 24 | -24.0% | 26.1% | ||
| Q2 24 | -14.7% | 30.2% | ||
| Q1 24 | -36.0% | 33.6% |
净利率
APLS
KOS
| Q4 25 | -29.5% | — | ||
| Q3 25 | 47.0% | -40.0% | ||
| Q2 25 | -23.6% | -22.3% | ||
| Q1 25 | -55.3% | -38.1% | ||
| Q4 24 | -17.1% | — | ||
| Q3 24 | -29.2% | 11.0% | ||
| Q2 24 | -18.9% | 13.3% | ||
| Q1 24 | -38.5% | 21.7% |
每股收益(稀释后)
APLS
KOS
| Q4 25 | $-0.40 | $-0.80 | ||
| Q3 25 | $1.67 | $-0.26 | ||
| Q2 25 | $-0.33 | $-0.18 | ||
| Q1 25 | $-0.74 | $-0.23 | ||
| Q4 24 | $-0.30 | $0.00 | ||
| Q3 24 | $-0.46 | $0.09 | ||
| Q2 24 | $-0.30 | $0.12 | ||
| Q1 24 | $-0.54 | $0.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $91.5M |
| 总债务越低越好 | — | $3.1B |
| 股东权益账面价值 | $370.1M | $528.6M |
| 总资产 | $1.1B | $4.7B |
| 负债/权益比越低杠杆越低 | — | 5.78× |
8季度趋势,按日历期对齐
现金及短期投资
APLS
KOS
| Q4 25 | $466.2M | $91.5M | ||
| Q3 25 | $479.2M | $64.0M | ||
| Q2 25 | $370.0M | $51.7M | ||
| Q1 25 | $358.4M | $49.8M | ||
| Q4 24 | $411.3M | $85.0M | ||
| Q3 24 | $396.9M | $51.6M | ||
| Q2 24 | $360.1M | $173.8M | ||
| Q1 24 | $325.9M | $254.3M |
总债务
APLS
KOS
| Q4 25 | — | $3.1B | ||
| Q3 25 | — | $3.0B | ||
| Q2 25 | — | $2.9B | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益
APLS
KOS
| Q4 25 | $370.1M | $528.6M | ||
| Q3 25 | $401.2M | $898.8M | ||
| Q2 25 | $156.3M | $1.0B | ||
| Q1 25 | $164.2M | $1.1B | ||
| Q4 24 | $228.5M | $1.2B | ||
| Q3 24 | $237.1M | $1.2B | ||
| Q2 24 | $264.3M | $1.1B | ||
| Q1 24 | $266.7M | $1.1B |
总资产
APLS
KOS
| Q4 25 | $1.1B | $4.7B | ||
| Q3 25 | $1.1B | $5.1B | ||
| Q2 25 | $821.4M | $5.2B | ||
| Q1 25 | $807.3M | $5.3B | ||
| Q4 24 | $885.1M | $5.3B | ||
| Q3 24 | $901.9M | $5.5B | ||
| Q2 24 | $904.5M | $5.4B | ||
| Q1 24 | $831.9M | $5.4B |
负债/权益比
APLS
KOS
| Q4 25 | — | 5.78× | ||
| Q3 25 | — | 3.31× | ||
| Q2 25 | — | 2.80× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.29× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $35.3M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | — |
| 自由现金流率自由现金流/营收 | -7.1% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | — |
8季度趋势,按日历期对齐
经营现金流
APLS
KOS
| Q4 25 | $-14.2M | $35.3M | ||
| Q3 25 | $108.5M | $-27.6M | ||
| Q2 25 | $4.4M | $127.2M | ||
| Q1 25 | $-53.4M | $-888.0K | ||
| Q4 24 | $19.4M | $175.7M | ||
| Q3 24 | $34.1M | $6.3M | ||
| Q2 24 | $-8.3M | $223.7M | ||
| Q1 24 | $-133.0M | $272.6M |
自由现金流
APLS
KOS
| Q4 25 | $-14.3M | — | ||
| Q3 25 | $108.3M | — | ||
| Q2 25 | $4.4M | — | ||
| Q1 25 | $-53.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-8.4M | — | ||
| Q1 24 | $-133.3M | — |
自由现金流率
APLS
KOS
| Q4 25 | -7.1% | — | ||
| Q3 25 | 23.6% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | -32.0% | — | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -4.2% | — | ||
| Q1 24 | -77.3% | — |
资本支出强度
APLS
KOS
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.2% | — |
现金转化率
APLS
KOS
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 3.74× | ||
| Q1 24 | — | 2.97× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
KOS
| Ghana Segment | $134.6M | 46% |
| Gulf Of America | $80.7M | 27% |
| Mauritania And Senegal | $54.9M | 19% |
| Equatorial Guinea Segment | $24.3M | 8% |